![Robert Woods](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
En la actualidad, R. Keith Woods ocupa el cargo de Director de Operaciones de argenx SE. En su trayectoria profesional anterior, ocupó el cargo de SVP-North American Operations en Alexion Pharmaceuticals, Inc. y de Vicepresidente y Director General en Alexion Pharma UK Ltd. (una filial de Alexion Pharmaceuticals, Inc.). (una filial de Alexion Pharmaceuticals, Inc.). Se licenció en la Universidad Estatal de Florida.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/04/2026 | 48.034 ( 0,04 % ) | 2 M $ | 31/05/2026 | |
X4 PHARMACEUTICALS, INC. 0,01 % | 09/06/2025 | 6.000 ( 0,01 % ) | 25 860 $ | 31/05/2026 |
-.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 06/12/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Director de Operaciones | 27/04/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 22/08/2025 |
| ROCKET PHARMACEUTICALS, INC. | Director de Operaciones | 18/06/2025 |
| ARGENX SE | Corporate Officer/Principal | 01/06/2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
